Related references
Note: Only part of the references are listed.Molecular Pathogenesis of Ewing Sarcoma: New Therapeutic and Transcriptional Targets
Stephen L. Lessnick et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers
Christina Yau et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
Nu Zhang et al.
CANCER CELL (2011)
FoxM1 in Tumorigenicity of the Neuroblastoma Cells and Renewal of the Neural Progenitors
Zebin Wang et al.
CANCER RESEARCH (2011)
FoxM1: A Master Regulator of Tumor Metastasis
Pradip Raychaudhuri et al.
CANCER RESEARCH (2011)
Thiostrepton, proteasome inhibitors and FOXM1
Andrei L. Gartel
CELL CYCLE (2011)
Expression of FoxM1 Is Required for the Proliferation of Medulloblastoma Cells and Indicates Worse Survival of Patients
Markus Priller et al.
CLINICAL CANCER RESEARCH (2011)
ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance
Julie Millour et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The transcription factor FOXM1 is a cellular target of the natural product thiostrepton
Nagaratna S. Hegde et al.
NATURE CHEMISTRY (2011)
Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells
Gabriel T. M. Lok et al.
PLOS ONE (2011)
Forkhead box M1 transcription factor: A novel target for cancer therapy
Zhiwei Wang et al.
CANCER TREATMENT REVIEWS (2010)
FoxM1, a critical regulator of oxidative stress during oncogenesis
Hyun Jung Park et al.
EMBO JOURNAL (2009)
GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
Elspeth Beauchamp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Transcriptional Up-Regulation of FoxM1 in Response to Hypoxia Is Mediated by HIF-1
Li-Min Xia et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
Hayriye V. Erkizan et al.
NATURE MEDICINE (2009)
Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
Uppoor G. Bhat et al.
PLOS ONE (2009)
FoxM1 Is a General Target for Proteasome Inhibitors
Uppoor G. Bhat et al.
PLOS ONE (2009)
GLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors
Jay Joo et al.
PLOS ONE (2009)
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch et al.
SCIENCE (2009)
Proteasome inhibitor Bortezomib induces cell cycle arrest and apoptosis in cell lines derived from Ewing's sarcoma family of tumors and synergizes with TRAIL
Guangrong Lu et al.
CANCER BIOLOGY & THERAPY (2008)
Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
Jimmy M-M. Kwok et al.
MOLECULAR CANCER THERAPEUTICS (2008)
EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
Leah A. Owen et al.
PLOS ONE (2008)
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2008)
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
J. P. Zwerner et al.
ONCOGENE (2008)
FOXM1, a typical proliferation-associated transcription factor
Inken Wierstra et al.
BIOLOGICAL CHEMISTRY (2007)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma
Michelle Kinsey et al.
MOLECULAR CANCER RESEARCH (2006)
Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1
Senthil K. Radhakrishnan et al.
CANCER RESEARCH (2006)
FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells
MG Liu et al.
CANCER RESEARCH (2006)
Dual degradation signals control Gli protein stability and tumor formation
EG Huntzicker et al.
GENES & DEVELOPMENT (2006)
Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe
DR Wonsey et al.
CANCER RESEARCH (2005)
A Multicenter phase II study of bortezomib in recurrent or metastatic sarcomas
RG Maki et al.
CANCER (2005)
FoxM1 is required for execution of the mitotic programme and chromosome stability
J Laoukili et al.
NATURE CELL BIOLOGY (2005)
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: Evaluation of combination ifosfamide and etoposide - A children's cancer group and pediatric oncology group study
JS Miser et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data
C Pilarsky et al.
NEOPLASIA (2004)
Share Paper
